CS logo
small CS logo
Nemocnice Kyjov, p.o.

Kyjov, Czechia
Hospital in Kyjov
Strážovská 1247/22, 697 01 Kyjov

About Nemocnice Kyjov, p.o.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
2
Limacorporate S.p.a
2
Hoffmann-La Roche
1
Pfizer
1
Sunovion Respiratory Development Inc.
1
Total Rows: 5

Clinical Trials at Nemocnice Kyjov, p.o.


During the past decade, Nemocnice Kyjov, p.o. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years3311002211001122Started TrialsCompleted Trails201820192020202101234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
2014-10-01
2016-02-01
Completed
1,087
A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.
2018-04-05
2023-02-23
Completed
421
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection
2018-01-03
2020-04-30
Terminated
334
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications
2018-01-21
2020-08-24
Terminated
553
Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza
2019-01-08
2020-03-16
Completed
363
Hip Arthroplasty With SL Cementless
2021-06-08
2023-06-08
Recruiting
62
Hip Arthroplasty With Logica Mirror Femoral Stem
2021-06-07
2026-06-07
Recruiting
43

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Nemocnice Kyjov, p.o." #1 sponsor was "Janssen Research & Development, LLC" with 2 trials, followed by "Limacorporate S.p.a" with 2 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Sunovion Respiratory Development Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Nemocnice Kyjov, p.o." #1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "Innovative Medicines Initiative (IMI) COMBACTE-CARE (EU)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsJanssen Research &Development, LLC: 2Janssen Research &Development, LLC: 2Limacorporate S.p.a: 2Limacorporate S.p.a: 2Hoffmann-La Roche: 1Hoffmann-La Roche: 1Pfizer: 1Pfizer: 1Sunovion RespiratoryDevelopment Inc.: 1Sunovion RespiratoryDevelopment Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsBiomedical AdvancedResearch andDevelopment Authority:1Biomedical AdvancedResearch andDevelopment Authority:1Innovative MedicinesInitiative (IMI)COMBACTE-CARE (EU):1Innovative MedicinesInitiative (IMI)COMBACTE-CARE (EU):1

Clinical Trials Conditions at Nemocnice Kyjov, p.o.


According to Clinical.Site data, the most researched conditions in "Nemocnice Kyjov, p.o." are "Hip Replacement" (2 trials), "Influenza A" (2 trials), "Chronic Obstructive Pulmonary Disease (COPD)" (1 trials), "Complicated Intra-abdominal Infection" (1 trials) and "Hosptial Acquired Pneumonia" (1 trials). Many other conditions were trialed in "Nemocnice Kyjov, p.o." in a lesser frequency.

Clinical Trials Intervention Types at Nemocnice Kyjov, p.o.


Most popular intervention types in "Nemocnice Kyjov, p.o." are "Drug" (5 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Pimodivir 600 mg" (2 trials), "SOC Treatment" (2 trials), "ATM-AVI" (1 trials) and "Baloxavir Marboxil" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Nemocnice Kyjov, p.o.


The vast majority of trials in "Nemocnice Kyjov, p.o." are 7 trials for "All" genders.

Clinical Trials Status at Nemocnice Kyjov, p.o.


Currently, there are NaN active trials in "Nemocnice Kyjov, p.o.". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Nemocnice Kyjov, p.o., undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Nemocnice Kyjov, p.o., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5Not Applicable: 2Not Applicable: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 3Completed: 3Recruiting: 2Recruiting: 2Terminated: 2Terminated: 2